Furthermore, BRAF-mutated melanoma is connected with shorter survival in stage IV disease and V600E expressed in the nucleus (rather than the cytoplasm) is associated with more advanced tumour staging, lymph node metastasis and depth of invasion [92,101]. The gene discussed is BRAF; the disease is neoplasm.